🇺🇸 FDA
Patent

US 10946023

Therapeutically active compounds and their methods of use

granted A61KA61K31/506A61K31/53

Quick answer

US patent 10946023 (Therapeutically active compounds and their methods of use) held by Agios Pharmaceuticals, Inc. expires Mon Mar 11 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Agios Pharmaceuticals, Inc.
Grant date
Tue Mar 16 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 11 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
35
CPC classes
A61K, A61K31/506, A61K31/53, A61K31/5377, A61K45/06